The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery

Conditions: Eyelid Diseases, Periorbital Disorder, Hemorrhage, Surgical Blood Loss

Sex: All

Ages: 18 Years – N/A

Phase: PHASE4

Enrollment: 150

Sponsor: University of Miami

Summary

This study investigates the effect of tranexamic acid, a medication that helps reduce bleeding, in patients undergoing surgeries around their eyes.

Eligibility Criteria

Inclusion Criteria:Adults age 18 and above undergoing periorbital oculoplastic surgery including but not limited to upper and lower blepharoplasty, four lid procedures, or dacryocystorhinostomy (DCR).Exclusion Criteria:- Adults unable to consentIndividuals less than 18 years of agePrisonersPregnant women.Known contradictions or sensitivities to study medication (tranexamic acid)Patients with known prior thromboembolic eventsPrevious eyelid surgery or same-side DCR (RE-DCR)Has any type of coagulopathy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05672407). StuddyBuddy aggregates publicly available trial information.